DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT) Meeting Abstract
| Authors: | Kasper, B.; Ratan, R.; Alcindor, T.; Schoeffski, P.; van Der Graaf, W. T. A.; Wilky, B. A.; Riedel, R. F.; Lim, A.; Smith, L. M.; Moody, S.; Attia, S.; Chawla, S. P.; D'Amato, G.; Federman, N.; Van Tine, P.; Van Tine, B. A.; Vincenzi, B.; Kummar, S.; Gounder, M. M. |
| Abstract Title: | DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1435 |
| End Page: | S1436 |
| Language: | English |
| ACCESSION: | WOS:000866211602485 |
| DOI: | 10.1016/j.annonc.2022.08.075 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA2 -- Source: Wos |
